Market Chatter: GSK, Sanofi, CSL Awarded $72 Million From US Government to Boost Bird Flu Vaccine Production

MT Newswires Live00:58

GSK (GSK), Sanofi (SNY), and CSL Ltd. were awarded $72 million by the US government to increase bird flu vaccine production, Bloomberg reported Friday, citing an interview with Dawn O'Connell, assistant secretary for preparedness and response at the US Department of Health and Human Services.

The funding will be used by the companies to fill vials and pre-filled syringes with vaccine ingredients, aiming to increase the US supply to of ready-to-use vaccines to 10 million doses by Q1 2025, O'Connell said.

CSL will receive $37.9 million, Sanofi $23.4 million, and GSK $10.5 million to more than double the supply of bird flu vaccines in the US, Bloomberg reported.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 38.51, Change: +0.14, Percent Change: +0.35

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment